Literature DB >> 25120095

Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice.

Hongfeng Jiang1, Marit Westerterp, Chunjiong Wang, Yi Zhu, Ding Ai.   

Abstract

AIMS/HYPOTHESIS: Inflammatory factors secreted by macrophages play an important role in obesity-related insulin resistance. Being at the crossroads of a nutrient-hormonal signalling network, the mammalian target of rapamycin complex 1 (mTORC1) controls important functions in the regulation of energy balance and peripheral metabolism. However, the role of macrophage mTORC1 in insulin resistance is still unclear. In the current study, we investigated the physiological role of macrophage mTORC1 in regulating inflammation and insulin sensitivity.
METHODS: We generated mice deficient in the regulatory associated protein of mTOR (Raptor) in macrophages, by crossing Raptor (also known as Rptor) floxed mice (Raptor (flox/flox)) with mice expressing Cre recombinase under the control of the Lysm-Cre promoter (Mac-Raptor (KO)). We fed mice chow or high-fat diet (HFD) and assessed insulin sensitivity in liver, muscle and adipose tissue. Subsequently, we measured inflammatory gene expression in liver and adipose tissue and investigated the role of Raptor deficiency in the regulation of inflammatory responses in peritoneal macrophages from HFD-fed mice or in palmitic acid-stimulated bone marrow-derived macrophages (BMDMs).
RESULTS: Mac-Raptor (KO) mice fed HFD had improved systemic insulin sensitivity compared with Raptor (flox/flox) mice. Macrophage Raptor deficiency reduced inflammatory gene expression in liver and adipose tissue, fatty liver and adipose tissue macrophage content in response to HFD. In peritoneal macrophages from mice fed with an HFD for 12 weeks, macrophage Raptor deficiency decreased inflammatory gene expression, through attenuation of the inactivation of Akt and subsequent inhibition of the inositol-requiring element 1α/clun NH2-terminal kinase-nuclear factor kappa-light-chain-enhancer of activated B cells (IRE1α/JNK/NFκB) pathways. Similarly, mTOR inhibition as a result of Raptor deficiency or rapamycin treatment decreased palmitic acid-induced inflammatory gene expression in BMDMs in vitro. CONCLUSIONS/
INTERPRETATION: The disruption of mTORC1 signalling in macrophages protects mice against inflammation and insulin resistance potentially by inhibiting HFD- and palmitic acid-induced IRE1α/JNK/NFκB pathway activation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25120095     DOI: 10.1007/s00125-014-3350-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

1.  Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.

Authors:  Ding Ai; Juan M Baez; Hongfeng Jiang; Donna M Conlon; Antonio Hernandez-Ono; Maria Frank-Kamenetsky; Stuart Milstein; Kevin Fitzgerald; Andrew J Murphy; Connie W Woo; Alanna Strong; Henry N Ginsberg; Ira Tabas; Daniel J Rader; Alan R Tall
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.

Authors:  Wen Qiang Chen; Lin Zhong; Lei Zhang; Xiao Ping Ji; Mei Zhang; Yu Xia Zhao; Cheng Zhang; Yun Zhang
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 3.  Interaction between free fatty acids and glucose metabolism.

Authors:  Guenther Boden
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-09       Impact factor: 4.294

4.  Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils.

Authors:  Shyra J Gardai; David A Hildeman; Steve K Frankel; Ben B Whitlock; S Courtney Frasch; Niels Borregaard; Philippa Marrack; Donna L Bratton; Peter M Henson
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

5.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

6.  Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.

Authors:  Frédéric Tremblay; Sophie Brûlé; Sung Hee Um; Yu Li; Kohei Masuda; Michael Roden; Xiao Jian Sun; Michael Krebs; Roberto D Polakiewicz; George Thomas; André Marette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

7.  Endoplasmic reticulum stress plays a central role in development of leptin resistance.

Authors:  Lale Ozcan; Ayse Seda Ergin; Allen Lu; Jason Chung; Sumit Sarkar; Duyu Nie; Martin G Myers; Umut Ozcan
Journal:  Cell Metab       Date:  2009-01-07       Impact factor: 27.287

8.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

9.  Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis.

Authors:  Ebru Erbay; Vladimir R Babaev; Jared R Mayers; Liza Makowski; Khanichi N Charles; Melinda E Snitow; Sergio Fazio; Michelle M Wiest; Steven M Watkins; Macrae F Linton; Gökhan S Hotamisligil
Journal:  Nat Med       Date:  2009-11-29       Impact factor: 53.440

10.  C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.

Authors:  Amrom E Obstfeld; Eiji Sugaru; Marie Thearle; Anne-Marie Francisco; Constance Gayet; Henry N Ginsberg; Eleanore V Ables; Anthony W Ferrante
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more
  33 in total

1.  Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease.

Authors:  Chunjiong Wang; Wenli Liu; Liu Yao; Xuejiao Zhang; Xu Zhang; Chenji Ye; Hongfeng Jiang; Jinlong He; Yi Zhu; Ding Ai
Journal:  Br J Pharmacol       Date:  2017-06-09       Impact factor: 8.739

2.  Exercise prevents the adverse effects of maternal obesity on placental vascularization and fetal growth.

Authors:  Jun Seok Son; Xiangdong Liu; Qiyu Tian; Liang Zhao; Yanting Chen; Yun Hu; Song Ah Chae; Jeanene M de Avila; Mei-Jun Zhu; Min Du
Journal:  J Physiol       Date:  2019-05-28       Impact factor: 5.182

3.  mTORC2 Signaling Selectively Regulates the Generation and Function of Tissue-Resident Peritoneal Macrophages.

Authors:  Min-Hee Oh; Samuel L Collins; Im-Hong Sun; Ada J Tam; Chirag H Patel; Matthew L Arwood; Yee Chan-Li; Jonathan D Powell; Maureen R Horton
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

4.  Intestinal epithelial cell-specific Raptor is essential for high fat diet-induced weight gain in mice.

Authors:  Emily J Onufer; Shirli Tay; Lauren K Barron; Cathleen M Courtney; Brad W Warner; Jun Guo
Journal:  Biochem Biophys Res Commun       Date:  2018-10-12       Impact factor: 3.575

Review 5.  Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance.

Authors:  Kalyana C Nandipati; Saravanan Subramanian; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-11-21       Impact factor: 3.396

Review 6.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 7.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 8.  Control of macrophage metabolism and activation by mTOR and Akt signaling.

Authors:  Anthony J Covarrubias; H Ibrahim Aksoylar; Tiffany Horng
Journal:  Semin Immunol       Date:  2015-09-07       Impact factor: 11.130

Review 9.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

10.  Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy.

Authors:  Jie Zhu; Ya Zheng; Haiyan Zhang; Jing Zhu; Hong Sun
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.